Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III double-blind randomized trial of bilastine (TAC-202) in perennial allergic rhinitis
jRCT2080222549Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bilastine in perennial rhinitis (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
bilastine
03
Conditions
perennial rhinitis
Beyond the preview
Go deeper on jRCT2080222549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222549.